tiprankstipranks
Trending News
More News >
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX

Royalty Pharma (RPRX) Revenue

Compare
1,254 Followers

Royalty Pharma Revenue

Royalty Pharma had a revenue of 594.00M in the quarter ending Dec 31, 2024, with 5.19%. This bring the company's revenue in the last twelve months to 2.26B, Increased -0.09%. In the fiscal year ending Dec 31, 2024, Royalty Pharma had annual revenue of 2.26B with -3.85% growth.
Revenue (ttm)
2.26B
Revenue Growth
1.15%
P/S Ratio
8.02
Revenue/Employee
$30,186,667
Employees
75
Market Cap
$18.17B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
2.26B-90.55M-3.85%
Dec 31, 2023
2.35B117.34M+5.24%
Dec 31, 2022
2.24B-52.25M-2.28%
Dec 31, 2021
2.29B167.46M+7.89%
Dec 31, 2020
2.12B307.75M+16.96%
Dec 31, 2019
1.81B19.36M+1.08%
Dec 31, 2018
1.79B196.96M+12.33%
Dec 31, 2017
1.60B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis